Description
MIRADDER ER 50 MG (Metoprolol + Hydrochlorothiazide)
Indications
MIRADDER ER is indicated for the treatment of hypertension and to reduce the risk of cardiovascular events in patients with a history of heart disease.
Mechanism of Action
MIRADDER ER combines Metoprolol, a selective beta-1 adrenergic blocker, which decreases heart rate and myocardial contractility, with Hydrochlorothiazide, a thiazide diuretic that reduces blood pressure by decreasing blood volume and vascular resistance.
Pharmacological Properties
Metoprolol is absorbed rapidly and extensively, with a bioavailability of approximately 50%. Hydrochlorothiazide is also well absorbed, with a peak effect occurring within 2-4 hours. The combination enhances antihypertensive efficacy and provides a synergistic effect.
Contraindications
MIRADDER ER is contraindicated in patients with known hypersensitivity to Metoprolol, Hydrochlorothiazide, or any component of the formulation, as well as in patients with severe bradycardia, heart block greater than first degree, cardiogenic shock, or acute decompensated heart failure.
Side Effects
Common side effects may include dizziness, fatigue, headache, and gastrointestinal disturbances. Serious side effects can include hypotension, bradycardia, and electrolyte imbalances.
Dosage and Administration
The recommended starting dose for adults is one tablet of MIRADDER ER 50 MG taken orally once daily. Dosage may be adjusted based on individual response and tolerability.
Interactions
MIRADDER ER may interact with other antihypertensive agents, non-steroidal anti-inflammatory drugs (NSAIDs), and certain antidepressants. It is important to inform your healthcare provider of all medications you are taking.
Precautions
Use with caution in patients with a history of asthma, diabetes, or renal impairment. Regular monitoring of blood pressure and renal function is recommended during treatment.
Clinical Studies
Clinical studies have demonstrated that the combination of Metoprolol and Hydrochlorothiazide effectively lowers blood pressure and reduces the incidence of cardiovascular events compared to monotherapy.
Conclusion
MIRADDER ER 50 MG is an effective combination therapy for managing hypertension and reducing cardiovascular risk. Patients should be monitored for efficacy and side effects throughout treatment.
IMPORTANT
This medication should be taken exactly as prescribed. Do not stop taking it suddenly without consulting your healthcare provider, as this may worsen your condition.
